ArticleThe oncologist2020

Potential Roles for PD-1 Inhibition and Cabozantinib in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma.

Andrew W Hahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.